查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948297

2026年全球外科止血劑市場報告

Surgical Hemostats Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，外科止血器械市場成長顯著，預計將從2025年的39.3億美元成長到2026年的42億美元，複合年成長率為6.9%。過去幾年成長要素包括外科手術數量的增加、對止血的需求、外科器械的進步、醫院基礎設施的擴建以及患者安全意識的提高。

預計未來幾年，外科止血劑市場規模將強勁成長，2030年將達到54.1億美元，複合年成長率（CAGR）為6.5%。預測期內的成長可歸因於止血產品的創新、機器人輔助手術的普及、門診手術中心的增加、人工智慧在醫療保健領域的應用以及對可生物分解止血劑的需求。預測期內的關鍵趨勢包括微創手術技術、先進止血材料的研發、照護現場止血監測、人工智慧在手術規劃中的應用以及環保永續的外科用品。

預計創傷病例的增加將在不久的將來推動外科止血劑市場的成長。創傷是指由於某種事件導致個體身心受到疼痛或傷害，並伴隨身體損傷或心理創傷。創傷病例的增加主要是因為交通事故的急劇增加，導致嚴重傷害需要緊急醫療照護。外科止血劑能夠快速有效地控制創傷病例的出血，減少失血量，穩定患者病情，以便進行後續治療。例如，威斯康辛州衛生服務部報告稱，2023年因攻擊造成的創傷病例比2022年增加了3%，從1544例增加到1584例。因此，創傷病例的成長趨勢正在推動外科止血劑市場的擴張。

主要企業正致力於開發先進的解決方案，例如室溫穩定的密封貼片，以改善止血效果、提高手術室效率並克服低溫運輸儲存的挑戰。室溫密封貼片是新一代止血墊，無需冷藏即可保持其全部功能。與傳統的冷藏或笨重的海綿止血貼相比，它們具有更高的柔軟性、更快的展開速度和更方便的使用方式。例如，2025年5月，總部位於美國的醫療保健公司百特國際（Baxter International）推出了Hemopatch Sealing Hemostat RT，這是一種新型的膠原蛋白蛋白貼片，旨在為開放性手術手術和微創手術提供有效的止血效果。此貼片結合了可生物分解的牛真皮膠原膠原蛋白基質和一層薄薄的NHS-PEG層，後者在接觸體液後會形成水凝膠，從而實現快速的組織黏附和密封，同時支持血小板的自然活性。止血效果可在約兩分鐘內實現，具有良好的生物相容性，並在六至八週內完全吸收。它還具有實際優勢，例如室溫儲存和長達 36 個月的保存期限，從而改善手術工作流程和供應鏈柔軟性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球外科止血劑市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 自主系統、機器人與智慧運輸
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
  • 主要趨勢
    • 微創手術技術
    • 先進止血材料的研發
    • 床邊止血監測
    • 將人工智慧融入手術計劃
    • 環保永續的外科耗材

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 專科診所
  • 創傷中心
  • 門診手術中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球外科止血劑市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球外科止血劑市場規模、比較及成長率分析
  • 全球外科止血劑市場表現：規模與成長，2020-2025年
  • 全球外科止血劑市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球總潛在市場（TAM）

第9章 市場細分

  • 依產品類型
  • 局部使用凝血酶止血劑、液體止血劑、膠原蛋白止血劑、氧化再生纖維素止血劑、明膠止血劑、複合止血劑及其他產品類型
  • 配方
  • 基質和凝膠止血劑、海綿止血劑、片狀和墊狀止血劑、粉末止血劑
  • 透過使用
  • 神經外科、整形外科、心血管外科、婦科手術、創傷、整形外科及其他適應症
  • 最終用戶
  • 醫院、門診手術中心、專科診所和其他最終用戶
  • 依類型細分：局部用凝血酶類止血劑
  • 人類凝血酶類止血劑、牛凝血酶類止血劑、重組凝血酶類止血劑，劑型：凝膠、噴霧劑、粉末、海綿劑
  • 按類型細分：流動性止血劑
  • 含凝血酶的明膠基質、膠原蛋白基液體止血劑、合成聚合物基液體止血劑
  • 按類型細分：膠原蛋白類止血劑
  • 微纖維膠原膠原蛋白、不織布膠原蛋白墊、膠原蛋白絨或膠原蛋白片
  • 按類型細分：氧化再生纖維素止血劑
  • 織布氧化再生纖維素布、不織布氧化再生纖維素墊、添加劑氧化再生纖維素
  • 按類型細分：明膠類止血劑
  • 明膠海綿、明膠粉、含凝血酶的明膠泡沫
  • 按類型細分：複合止血劑
  • 明膠+凝血酶、膠原蛋白+凝血酶、氧化再生纖維素+凝血酶
  • 按類型細分：其他產品類型
  • 幾丁聚醣止血劑、高嶺土類止血劑、合成胜肽止血劑、植物來源止血劑

第10章 區域與國家分析

  • 全球外科止血劑市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球外科止血劑市場：依國家、表現及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 外科止血劑市場：競爭格局及市場佔有率（2024年）
  • 外科止血劑市場：公司估值矩陣
  • 外科止血劑市場：公司概況
    • Thermo Fisher Scientific Inc
    • Danaher Corporation
    • Agilent Technologies Inc
    • PerkinElmer Inc
    • Mettler Toledo International Inc

第37章：其他領先和創新企業

  • Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes BV, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年外科止血劑市場：提供新機會的國家
  • 2030年外科止血劑市場：充滿新機會的細分市場
  • 2030年外科止血劑市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MSHEM01_G26Q1

Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.

The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.

Tariffs have influenced the surgical hemostats market by affecting the cost and availability of raw materials such as collagen, gelatin, and synthetic polymers used in hemostatic products. Increased tariffs have raised production costs, particularly for matrix and gel hemostats, flowable hemostats, and topical thrombin-based hemostats, impacting key regions like North America and Europe where imports are significant. While this has created challenges for manufacturers, it has also encouraged local production and sourcing strategies, potentially reducing dependency on imports and driving innovation in cost-effective hemostat solutions.

The surgical hemostats market research report is one of a series of new reports from The Business Research Company that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. This surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The surgical hemostats market size has grown strongly in recent years. It will grow from $3.93 billion in 2025 to $4.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising surgical procedures, demand for blood loss management, advancement in surgical instruments, increase in hospital infrastructure, awareness about patient safety.

The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to innovation in hemostatic products, adoption of robotic-assisted surgeries, growth in outpatient surgical centers, integration of ai in healthcare, demand for biodegradable hemostats. Major trends in the forecast period include minimally invasive surgical techniques, advanced hemostatic materials development, point-of-care hemostasis monitoring, integration of ai in surgical planning, eco-friendly and sustainable surgical supplies.

The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.

Major companies operating in the surgical hemostat market are concentrating on creating advanced solutions, such as room-temperature-stable sealing patches, to improve bleeding control, optimize operating-room efficiency, and overcome challenges related to cold-chain storage. Room-temperature sealing patches are next-generation hemostatic pads designed to retain full functionality without the need for refrigeration, providing enhanced flexibility, quicker deployment, and better accessibility compared with conventional refrigerated or bulky sponge-based hemostats. For example, in May 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat RT, its newest collagen-based patch developed for effective hemostasis in both open and minimally invasive surgeries. The patch combines a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that forms a hydrogel upon fluid contact, enabling fast tissue adhesion and sealing while supporting natural platelet activity. Achieving hemostasis generally within approximately two minutes, offering biocompatibility, and fully resorbing within 6-8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, enhancing surgical workflow and supply-chain flexibility.

In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Surgical Hemostats Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for surgical hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Topical Thrombin-Based Hemostats; Flowable Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Gelatin-Based Hemostats; Combination Hemostats; Other Product Types
  • 2) By Formulation: Matrix And Gel Hemostats; Sponge Hemostats; Sheet And Pad Hemostats; Powder Hemostats
  • 3) By Application: Neurological Surgery; Orthopedic Surgery; Cardiovascular Surgery; Gynecological Surgery; Trauma; Plastic Surgery; Other Applications
  • 4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats; Bovine Thrombin-Based Hemostats; Recombinant Thrombin-Based Hemostats; Formulations Gel, Spray, Powder, Sponge
  • 2) By Flowable Hemostats: Gelatin Matrix With Thrombin; Collagen-Based Flowables; Synthetic Polymer-Based Flowables
  • 3) By Collagen-Based Hemostats: Microfibrillar Collagen; Nonwoven Collagen Pads; Collagen Fleece Or Sheets
  • 4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric; Non-woven Oxidized Regenerated Cellulose Pads; Oxidized Regenerated Cellulose With Additives
  • 5) By Gelatin-Based Hemostats: Gelatin Sponge; Gelatin Powder; Gelatin Foam With Thrombin
  • 6) By Combination Hemostats: Gelatin + Thrombin; Collagen + Thrombin; Oxidized Regenerated Cellulose + Thrombin
  • 7) By Other Product Types: Chitosan-Based Hemostats; Kaolin-Based Hemostats; Synthetic Peptide Hemostats; Plant-Derived Agents
  • Companies Mentioned: Thermo Fisher Scientific Inc; Danaher Corporation; Agilent Technologies Inc; PerkinElmer Inc; Mettler Toledo International Inc; Shimadzu Corporation; Waters Corporation; Bruker Corporation; HORIBA Ltd; JEOL Ltd; Anton Paar GmbH; Renishaw plc; Metrohm AG; Genedata AG; HunterLab Europe GmbH; Avantes B V; JASCO Corporation; Wasatch Photonics Inc; Lablicate GmbH; StellarNet Inc; LabWare Inc; SciY Software GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Surgical Hemostats Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Surgical Hemostats Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Surgical Hemostats Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Surgical Hemostats Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Minimally Invasive Surgical Techniques
    • 4.2.2 Advanced Hemostatic Materials Development
    • 4.2.3 Point-Of-Care Hemostasis Monitoring
    • 4.2.4 Integration Of Ai In Surgical Planning
    • 4.2.5 Eco-Friendly And Sustainable Surgical Supplies

5. Surgical Hemostats Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Clinics
  • 5.4 Trauma Centers
  • 5.5 Outpatient Surgical Facilities

6. Surgical Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Surgical Hemostats Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Surgical Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Surgical Hemostats Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Surgical Hemostats Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Surgical Hemostats Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Surgical Hemostats Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Surgical Hemostats Market Segmentation

  • 9.1. Global Surgical Hemostats Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types
  • 9.2. Global Surgical Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats
  • 9.3. Global Surgical Hemostats Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications
  • 9.4. Global Surgical Hemostats Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
  • 9.5. Global Surgical Hemostats Market, Sub-Segmentation Of Topical Thrombin-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge
  • 9.6. Global Surgical Hemostats Market, Sub-Segmentation Of Flowable Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables
  • 9.7. Global Surgical Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets
  • 9.8. Global Surgical Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives
  • 9.9. Global Surgical Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin
  • 9.10. Global Surgical Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin
  • 9.11. Global Surgical Hemostats Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

10. Surgical Hemostats Market Regional And Country Analysis

  • 10.1. Global Surgical Hemostats Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Surgical Hemostats Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Surgical Hemostats Market

  • 11.1. Asia-Pacific Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Surgical Hemostats Market

  • 12.1. China Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Surgical Hemostats Market

  • 13.1. India Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Surgical Hemostats Market

  • 14.1. Japan Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Surgical Hemostats Market

  • 15.1. Australia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Surgical Hemostats Market

  • 16.1. Indonesia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Surgical Hemostats Market

  • 17.1. South Korea Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Surgical Hemostats Market

  • 18.1. Taiwan Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Surgical Hemostats Market

  • 19.1. South East Asia Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Surgical Hemostats Market

  • 20.1. Western Europe Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Surgical Hemostats Market

  • 21.1. UK Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Surgical Hemostats Market

  • 22.1. Germany Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Surgical Hemostats Market

  • 23.1. France Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Surgical Hemostats Market

  • 24.1. Italy Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Surgical Hemostats Market

  • 25.1. Spain Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Surgical Hemostats Market

  • 26.1. Eastern Europe Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Surgical Hemostats Market

  • 27.1. Russia Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Surgical Hemostats Market

  • 28.1. North America Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Surgical Hemostats Market

  • 29.1. USA Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Surgical Hemostats Market

  • 30.1. Canada Surgical Hemostats Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Surgical Hemostats Market

  • 31.1. South America Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Surgical Hemostats Market

  • 32.1. Brazil Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Surgical Hemostats Market

  • 33.1. Middle East Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Surgical Hemostats Market

  • 34.1. Africa Surgical Hemostats Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Surgical Hemostats Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Surgical Hemostats Market Regulatory and Investment Landscape

36. Surgical Hemostats Market Competitive Landscape And Company Profiles

  • 36.1. Surgical Hemostats Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Surgical Hemostats Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Surgical Hemostats Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. PerkinElmer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Mettler Toledo International Inc Overview, Products and Services, Strategy and Financial Analysis

37. Surgical Hemostats Market Other Major And Innovative Companies

  • Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc

38. Global Surgical Hemostats Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Surgical Hemostats Market

40. Surgical Hemostats Market High Potential Countries, Segments and Strategies

  • 40.1 Surgical Hemostats Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Surgical Hemostats Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Surgical Hemostats Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer